Showing 13,961 - 13,980 results of 122,558 for search '(( 2 e decrease ) OR ( 5 ((((a decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 2.16s Refine Results
  1. 13961

    Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

    Published 2025
    “…Morphological degradation of the catalyst material was only observed at current densities exceeding 1 A cm<sup>–2</sup> but not for smaller ones. Using X-ray absorption, X-ray photoemission spectroscopy, and X-ray diffraction, we confirmed that the degradation was accompanied by the literature-known transformation of nanoparticulate Ni<sub>3</sub>Se<sub>2</sub> (bulk)/NiSe (surface) into nickel oxyhydroxide. …”
  2. 13962

    Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

    Published 2025
    “…Morphological degradation of the catalyst material was only observed at current densities exceeding 1 A cm<sup>–2</sup> but not for smaller ones. Using X-ray absorption, X-ray photoemission spectroscopy, and X-ray diffraction, we confirmed that the degradation was accompanied by the literature-known transformation of nanoparticulate Ni<sub>3</sub>Se<sub>2</sub> (bulk)/NiSe (surface) into nickel oxyhydroxide. …”
  3. 13963

    Morphological Degradation of Oxygen Evolution Reaction-Electrocatalyzing Nickel Selenides at Industrially Relevant Current Densities by Felix Hiege (21700895)

    Published 2025
    “…Morphological degradation of the catalyst material was only observed at current densities exceeding 1 A cm<sup>–2</sup> but not for smaller ones. Using X-ray absorption, X-ray photoemission spectroscopy, and X-ray diffraction, we confirmed that the degradation was accompanied by the literature-known transformation of nanoparticulate Ni<sub>3</sub>Se<sub>2</sub> (bulk)/NiSe (surface) into nickel oxyhydroxide. …”
  4. 13964
  5. 13965
  6. 13966
  7. 13967
  8. 13968

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The charge delocalization between the <i>N</i>-heterocyclic carbene (NHC) and the metal in cationic molybdenum imido alkylidene NHC mono­(nonafluoro-<i>tert</i>-butoxide) complexes has been studied for different NHCs, i.e., 1,3-dimesitylimidazol-2-ylidene (IMes), 1,3-dimesityl-4,5-dichloroimidazol-2-ylidene (IMesCl<sub>2</sub>), 1,3-dimesityl-4,5-dimethylimidazol-2-ylidene (IMesMe<sub>2</sub>), and 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH<sub>2</sub>). …”
  9. 13969

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The charge delocalization between the <i>N</i>-heterocyclic carbene (NHC) and the metal in cationic molybdenum imido alkylidene NHC mono­(nonafluoro-<i>tert</i>-butoxide) complexes has been studied for different NHCs, i.e., 1,3-dimesitylimidazol-2-ylidene (IMes), 1,3-dimesityl-4,5-dichloroimidazol-2-ylidene (IMesCl<sub>2</sub>), 1,3-dimesityl-4,5-dimethylimidazol-2-ylidene (IMesMe<sub>2</sub>), and 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH<sub>2</sub>). …”
  10. 13970

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The charge delocalization between the <i>N</i>-heterocyclic carbene (NHC) and the metal in cationic molybdenum imido alkylidene NHC mono­(nonafluoro-<i>tert</i>-butoxide) complexes has been studied for different NHCs, i.e., 1,3-dimesitylimidazol-2-ylidene (IMes), 1,3-dimesityl-4,5-dichloroimidazol-2-ylidene (IMesCl<sub>2</sub>), 1,3-dimesityl-4,5-dimethylimidazol-2-ylidene (IMesMe<sub>2</sub>), and 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH<sub>2</sub>). …”
  11. 13971

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The charge delocalization between the <i>N</i>-heterocyclic carbene (NHC) and the metal in cationic molybdenum imido alkylidene NHC mono­(nonafluoro-<i>tert</i>-butoxide) complexes has been studied for different NHCs, i.e., 1,3-dimesitylimidazol-2-ylidene (IMes), 1,3-dimesityl-4,5-dichloroimidazol-2-ylidene (IMesCl<sub>2</sub>), 1,3-dimesityl-4,5-dimethylimidazol-2-ylidene (IMesMe<sub>2</sub>), and 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH<sub>2</sub>). …”
  12. 13972

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The charge delocalization between the <i>N</i>-heterocyclic carbene (NHC) and the metal in cationic molybdenum imido alkylidene NHC mono­(nonafluoro-<i>tert</i>-butoxide) complexes has been studied for different NHCs, i.e., 1,3-dimesitylimidazol-2-ylidene (IMes), 1,3-dimesityl-4,5-dichloroimidazol-2-ylidene (IMesCl<sub>2</sub>), 1,3-dimesityl-4,5-dimethylimidazol-2-ylidene (IMesMe<sub>2</sub>), and 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH<sub>2</sub>). …”
  13. 13973

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The charge delocalization between the <i>N</i>-heterocyclic carbene (NHC) and the metal in cationic molybdenum imido alkylidene NHC mono­(nonafluoro-<i>tert</i>-butoxide) complexes has been studied for different NHCs, i.e., 1,3-dimesitylimidazol-2-ylidene (IMes), 1,3-dimesityl-4,5-dichloroimidazol-2-ylidene (IMesCl<sub>2</sub>), 1,3-dimesityl-4,5-dimethylimidazol-2-ylidene (IMesMe<sub>2</sub>), and 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH<sub>2</sub>). …”
  14. 13974

    DataSheet_2_Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Periphe... by Klaudia Kwiatkowski (9118247)

    Published 2020
    “…In parallel, administration of cenicriviroc decreased the expression of CCR2 in the spinal cord and CCR5 in DRG. …”
  15. 13975

    Ca<sup>2+</sup> binding mutants expressed and localized correctly. by Mallory C. Shields (4474210)

    Published 2020
    “…<b>A. Below</b>, By replacing two aspartate residues with neutral (green) asparagines, the <i>syt<sup>D-N</sup></i> mutation in C<sub>2</sub>A blocks Ca<sup>2+</sup> binding and partially neutralizes the negative charge of the pocket. …”
  16. 13976

    Identification of novel pathogenic mutations in <i>ATP6V0A4</i> associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease by Yaru Jiang (17458815)

    Published 2025
    “…Notably, patients with <i>ATP6V0A4</i> mutations were diagnosed at a younger age (mean 0.5 years) and exhibited more severe renal impairment, including reduced estimated glomerular filtration rate (eGFR), indicating heightened susceptibility to kidney damage. …”
  17. 13977
  18. 13978
  19. 13979
  20. 13980